Skip to main content

Rhenman & Partners Asset Management AB

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1599882 Stockholm, V7

Position in BMRN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16,622,410
+$4,928,980 QoQ
Shares Held
290,500
+40.3% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
#87
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rhenman & Partners Asset Management AB holds $335,352,902 across 39 Biotechnology names. BMRN ranks #3 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 BMRN
Biomarin Pharmaceutical Inc
This page
290,500 $16,622,410

All Filings in BMRN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,622,410 290,500
2026-03-31 $11,693,430 207,000
2025-12-31 $12,777,450 215,000
2025-09-30 $10,108,964 186,650
2025-06-30 $8,226,260 149,650
2025-03-31 $18,732,850 265,000
2024-12-31 $16,473,449 250,623
2024-09-30 $25,620,705 364,500
2024-06-30 $20,705,995 251,500
2024-03-31 $20,743,250 237,500
2023-12-31 $27,238,650 282,500
2023-09-30 $33,622,400 380,000
2023-06-30 $32,938,400 380,000
2023-03-31 $21,879,000 225,000
2022-12-31 $26,286,460 254,000
2022-09-30 $20,090,490 237,000
2022-06-30 $11,601,800 140,000
2022-03-31 $16,962,000 220,000
2021-12-31 $23,412,750 265,000
2021-09-30 $18,549,600 240,000
2021-06-30 $13,350,400 160,000
2021-03-31 $13,591,800 180,000
2020-12-31 $44,721,900 510,000
2020-09-30 $56,630,452 744,354
2020-06-30 $23,434,600 190,000
2020-03-31 $15,619,402 184,845